General Atlantic, L.P. - Significant Ownership

Signature - Title
/s/ Michael Gosk - Michael Gosk, Managing Director
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by General Atlantic, L.P..

Significant Ownership of General Atlantic, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
DLO dLocal Ltd Class A common shares, nominal value $0.002 per share 28.3% $485M 46.7M GENERAL ATLANTIC, L.P. Sep 5, 2025
ALHC Alignment Healthcare, Inc. Class A common stock, par value $0.001 per share 12.3% $366M -$297M 24.3M -44.8% General Atlantic, L.P. Sep 17, 2025
ALKT ALKAMI TECHNOLOGY, INC. Common stock, par value $0.001 per share 11.6% $315M $61.7M 12M +24.4% General Atlantic, L.P. Aug 13, 2025
AKRO Akero Therapeutics, Inc. Common Stock, par value $0.0001 per share 8.4% $279M 6.8M General Atlantic, L.P. Mar 31, 2025
CHYM Chime Financial, Inc. Class A Common Stock, par value $0.0001 per share 5.6% $387M 19.2M General Atlantic, L.P. Jun 13, 2025
XP XP Inc. Class A common shares, par value US$0.00001 per share 5.4% $434M 22.8M GENERAL ATLANTIC, L.P. Dec 2, 2025
RPRX Royalty Pharma plc Class A ordinary shares, par value US$0.0001 per share 3.2% $511M 14.2M General Atlantic, L.P. Jun 30, 2025
THRD Third Harmonic Bio, Inc. Common stock, par value $0.0001 0% $0 -$18.7M 0 -100% General Atlantic, L.P. Feb 11, 2025
BLND Blend Labs, Inc. Class A common stock, par value $0.00001 per share 0% $0 0 General Atlantic, L.P. Dec 31, 2024

Schedules 13D/G Reported by General Atlantic, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.